Page 2 - Tim Dyer News Today

Geneva, Switzerland, January 9, 2024 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that Dr...

The 11th volume in Harpswell author James Nelson's magnificent "Norsemen Saga," and author and essayist Janna Malamud Smith's fascinating study of Vinalhaven

Geneva, Switzerland, November 23, 2023 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric...

Geneva, Switzerland, November 23, 2023 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that that...

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, November 8, 2023 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced it had received written notification from The Nasdaq Stock Market LLC (Nasdaq) that it has regained compliance with the minimum bid price requirement of $1.00 per ADS under Nasdaq Listing Rule 5550(a)(2) and currently meets all other applicable cr

Geneva, Switzerland, November 2, 2023 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that Tim...

Q-Tip has extended his musical talents to the Great White Way, revealing that he's joined the Broadway team behind the Muhammad Ali musical.

MADISON, Wis. -- Madisons east side might be a bit noisy through the next two weeks. Wisconsins 115th Fighter Wing, based at Truax Field, is running a series of nighttime

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, October 6, 2023 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that it plans to change the ratio of its American Depositary Shares (“ADSs”) to its ordinary shares (the “ADS Ratio”) from the current ADS Ratio of one (1) ADS to six (6) ordinary shares to a new ADS Ratio of one (1) ADS...

Addex Therapeutics Ltd (NASDAQ:ADXN, SGX:ADXN) co-founder and CEO Tim Dyer speaks to Thomas Warner from Proactive about the work that the central nervous...